Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / American Depositary Shares
- Total 13F shares
- 2,129,596
- Total 13F value
- $915,427
- Share change
- +1,801,647
- SEC-reported price per share
- $0.43
- Number of holders
- 16
- Value change
- +$790,699
- Number of buys
- 13
- Number of sells
- 2
- Shares outstanding
- 11,430,535
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
16
Top holders
10
KZIA full security history
Ownership snapshot
Full 13F holder table
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
11/11
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 1.8%
Showing 1-6 of 11 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 1.8%.
11 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
1.8%
BNP PARIBAS FINANCIAL MARKETS
0.56%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.36%
Virtu Financial LLC
0.34%
UBS Group AG
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
1.8%
|
$45,967
201,082 shares
|
— | 30 Jun 2024 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
0.56%
|
$14,532
63,568 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.36%
|
$9,457
41,478 shares
|
— | 30 Jun 2024 |
| Virtu Financial LLC |
13F
Company
|
0.34%
|
$9,000
39,277 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
0.2%
|
$5,344
23,336 shares
|
— | 30 Jun 2024 |
| RHUMBLINE ADVISERS |
13F
Company
|
0.15%
|
$4,014
17,615 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
2,129,596
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
11
Q3 2024 holders
16
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|